Chemical Structure : MAVDA-K-256
货号: PC-28781Not For Human Use, Lab Use Only.
MAVDA-K-256 is a potent and selective inhibitor of SARS-CoV-2 mRNA cap guanine-N7 methyltransferase (MTase) NSP14 with IC50 of <0.15 nM, inhibits SARS-CoV-2 replication with IC50 of 24.6 nM in Huh-7.5 cells.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MAVDA-K-256 is a potent and selective inhibitor of SARS-CoV-2 mRNA cap guanine-N7 methyltransferase (MTase) NSP14 with IC50 of <0.15 nM, inhibits SARS-CoV-2 replication with IC50 of 24.6 nM in Huh-7.5 cells.
MAVDA-K-256 engages NSP14 through the formation of a ternary complex with S-adenosyl-l-homocysteine, potently inhibiting its MTase activity.
MAVDA-K-256 demonstrates broad-spectrum antiviral activity against diverse hCoVs without targeting the host mRNA cap MTase.
MAVDA-K-256 inhibits the biochemical MTase activity of NSP14 proteins of hCoVs of different genera of the Coronaviridae family, with IC50 values of 18.1 and 8.4 nM (MERS), 11.9 and 5.6 nM (229E).
MAVDA-K-256 shows no inhibitory effects against a broad panel of 39 RNA, DNA, or protein MTases up to 10 uM.
MAVDA-K-256 demonstrates potent antiviral activity against α-hCoV-NL63 (EC50 = 0.72 μM) and α-hCoV-229E (EC50 = 1.22 μM), as well as β-hCoV-OC43 (EC50 = 0.2 μM), respectively.
MAVDA-K-256 shows antiviral efficacy in a K18-hACE2 transgenic mouse model of SARS-CoV-2 infection.
| 分子量 | 466.49 | |
| 分子式 | C23H19FN4O4S | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Meyer C, et al. J Med Chem. 2026 Nov 12;69(21):25760-25776.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright